Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:07 am
Author: Getaka|Social: XLinkedIn

IOL Chemicals & Pharmaceuticals Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹53.97Overvalued by 30.27%vs CMP ₹77.40

P/E (18.2) × ROE (6.1%) × BV (₹59.70) × DY (1.29%)

₹56.13Overvalued by 27.48%vs CMP ₹77.40
MoS: -37.9% (Negative)Confidence: 53/100 (Moderate)Models: 1 Under, 2 Fair, 6 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹50.2922%Over (-35%)
Graham NumberEarnings₹72.9316%Fair (-5.8%)
Earnings PowerEarnings₹31.5211%Over (-59.3%)
DCFCash Flow₹33.5413%Over (-56.7%)
Net Asset ValueAssets₹59.627%Over (-23%)
EV/EBITDAEnterprise₹69.239%Over (-10.6%)
Earnings YieldEarnings₹39.607%Over (-48.8%)
ROCE CapitalReturns₹92.419%Under (+19.4%)
Revenue MultipleRevenue₹70.795%Fair (-8.5%)
Consensus (9 models)₹56.13100%Overvalued

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -6.8%

*Investments are subject to market risks

Investment Snapshot

61
IOL Chemicals & Pharmaceuticals Ltd scores 61/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health70/100 · Strong
ROCE 8.9% AverageROE 6.1% AverageD/E 0.03 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money60/100 · Moderate
FII holding up 0.61% (6mo) Slight increasePromoter holding at 52.6% Stable
Earnings Quality60/100 · Moderate
OPM stable around 11% SteadyWorking capital: 58 days (improving) Efficient
Quarterly Momentum68/100 · Strong
Revenue (4Q): +8% YoY GrowingProfit (4Q): +19% YoY Positive
Industry Rank35/100 · Weak
P/E 18.2 vs industry 53.8 Cheaper than peersROCE 8.9% vs industry 16.4% Below peersROE 6.1% vs industry 15.2% Below peers3Y sales CAGR: -2% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:07 am

Market Cap 2,273 Cr.
Current Price 77.4
Intrinsic Value₹56.13
High / Low 127/57.5
Stock P/E18.2
Book Value 59.7
Dividend Yield1.29 %
ROCE8.86 %
ROE6.13 %
Face Value 2.00
PEG Ratio-2.67

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for IOL Chemicals & Pharmaceuticals Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
IOL Chemicals & Pharmaceuticals Ltd 2,273 Cr. 77.4 127/57.518.2 59.71.29 %8.86 %6.13 % 2.00
Dishman Carbogen Amcis Ltd 2,291 Cr. 146 322/12817.4 4060.00 %2.42 %0.32 % 2.00
Bliss GVS Pharma Ltd 2,427 Cr. 229 244/10522.0 1070.22 %11.7 %8.36 % 1.00
Unichem Laboratories Ltd 2,100 Cr. 298 712/27820.0 3460.00 %6.24 %5.59 % 2.00
Morepen Laboratories Ltd 2,038 Cr. 37.2 70.5/33.026.7 21.80.54 %15.1 %11.8 % 2.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of IOL Chemicals & Pharmaceuticals Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 523587563545520504502526523528552568580
Expenses 480491490481476454452484476465490510523
Operating Profit 43967364445051424763625757
OPM % 8%16%13%12%9%10%10%8%9%12%11%10%10%
Other Income 797788764577-6
Interest 5544432444434
Depreciation 12121416161617181919202020
Profit before tax 33886251323839262845464128
Tax % 27%25%25%26%28%25%24%26%26%30%25%26%25%
Net Profit 24654638232830192132343021
EPS in Rs 0.822.221.571.290.790.961.010.650.701.081.161.020.70

Last Updated: March 4, 2026, 8:46 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 2:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 5643855807119831,6851,8941,9672,1842,2172,1332,0792,227
Expenses 4683735296088631,2761,3211,3751,9271,9901,9011,8771,988
Operating Profit 961151102120410574592257227232202239
OPM % 17%3%9%14%12%24%30%30%12%10%11%10%11%
Other Income 111161016241725302213
Interest 605961686451216816161515
Depreciation 32293030303236394346637278
Profit before tax 5-75-39631336533571223189183138159
Tax % 35%-12%4%21%12%30%32%22%26%26%26%27%
Net Profit 3-67-40528237361445166140135101116
EPS in Rs 0.23-2.80-1.420.170.998.3212.7015.155.644.774.613.443.96
Dividend Payout % 0%0%0%0%0%0%5%8%14%17%22%23%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-2333.33%40.30%112.50%460.00%746.43%52.32%23.27%-62.70%-15.66%-3.57%-25.19%
Change in YoY Net Profit Growth (%)0.00%2373.63%72.20%347.50%286.43%-694.11%-29.05%-85.97%47.03%12.09%-21.61%

IOL Chemicals & Pharmaceuticals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:18%
5 Years:2%
3 Years:-2%
TTM:3%
Compounded Profit Growth
10 Years:13%
5 Years:-22%
3 Years:-17%
TTM:-11%
Stock Price CAGR
10 Years:21%
5 Years:-8%
3 Years:10%
1 Year:4%
Return on Equity
10 Years:18%
5 Years:14%
3 Years:8%
Last Year:6%

Last Updated: September 5, 2025, 7:50 am

Balance Sheet

Last Updated: December 10, 2025, 2:52 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 29485656565757595959595959
Reserves 1601601291321604177571,2021,3321,4481,5531,6291,692
Borrowings 377400453447422284593448033117159
Other Liabilities 17594135182214184297347526434600577503
Total Liabilities 7417027728178529421,1701,6101,9602,0212,2442,3822,413
Fixed Assets 4114034003744064124695125617519331,1701,142
CWIP 3344217271948105901012264
Investments 00000001220212121
Other Assets 2972953694224395036821,0481,2921,1591,1901,1681,185
Total Assets 7417027728178529421,1701,6101,9602,0212,2442,3822,413

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 78-47188312027347138091123290179
Cash from Investing Activity + -12-5-27-23-50-63-184-317-121-119-191-154
Cash from Financing Activity + -66509-60-70-197-272-58-2-4-9246
Net Cash Flow 1-2-01-113154-31-0770
Free Cash Flow 65-53-96171213391272-60-8618-34
CFO/OP 83%-413%34%82%105%83%102%88%60%75%144%97%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-281.00-389.00-402.00-345.00-302.00126.00515.00589.00213.00147.00199.0085.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 323155585443525679838190
Inventory Days 190279201201109666498957711195
Days Payable 11992102115834262799574123112
Cash Conversion Cycle 1032181541448067557479866973
Working Capital Days -55939362343466671727158
ROCE %11%-3%4%12%15%56%68%54%18%14%12%9%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 48.19%48.19%48.19%48.19%48.19%48.19%48.19%52.62%52.62%52.62%52.62%52.62%
FIIs 2.43%3.54%2.33%2.18%1.40%1.39%1.63%1.49%1.47%2.59%2.25%2.08%
DIIs 0.23%0.25%0.35%0.36%0.29%0.09%0.07%0.08%0.07%0.02%0.05%0.03%
Public 49.15%48.02%49.12%49.27%50.11%50.34%50.11%45.81%45.84%44.76%45.10%45.26%
No. of Shareholders 1,40,1771,26,0041,35,3971,34,2351,30,0031,28,6891,25,9791,26,7011,30,0021,25,0401,36,1291,33,531

Shareholding Pattern Chart

No. of Shareholders

IOL Chemicals & Pharmaceuticals Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal Nifty Microcap 250 Index Fund 25,342 0.2 1.1525,3422025-04-22 17:25:300%
Motilal Oswal S&P BSE Healthcare ETF 243 0.12 0.012432025-04-22 17:25:300%
Groww Nifty Total Market Index Fund 65 0.01 0652025-04-22 17:25:300%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22
FaceValue 2.0010.0010.0010.00
Basic EPS (Rs.) 3.4422.9023.7028.56
Diluted EPS (Rs.) 3.4422.9023.7028.56
Cash EPS (Rs.) 5.9033.6131.5635.93
Book Value[Excl.RevalReserv]/Share (Rs.) 57.49274.49256.81237.15
Book Value[Incl.RevalReserv]/Share (Rs.) 57.49274.49256.81237.15
Revenue From Operations / Share (Rs.) 70.83363.27377.64372.00
PBDIT / Share (Rs.) 7.6544.4042.8049.45
PBIT / Share (Rs.) 5.2033.6834.9442.08
PBT / Share (Rs.) 4.7030.9432.1338.30
Net Profit / Share (Rs.) 3.4422.9023.7028.56
NP After MI And SOA / Share (Rs.) 3.4422.9023.7028.56
PBDIT Margin (%) 10.8012.2211.3313.29
PBIT Margin (%) 7.349.279.2511.31
PBT Margin (%) 6.638.518.5010.29
Net Profit Margin (%) 4.866.306.277.67
NP After MI And SOA Margin (%) 4.866.306.277.67
Return on Networth / Equity (%) 5.988.349.2212.04
Return on Capital Employeed (%) 8.6111.7413.0917.05
Return On Assets (%) 4.245.986.888.54
Total Debt / Equity (X) 0.060.000.050.03
Asset Turnover Ratio (%) 0.890.991.110.00
Current Ratio (X) 1.892.002.022.11
Quick Ratio (X) 1.301.241.301.31
Inventory Turnover Ratio (X) 5.293.824.180.00
Dividend Payout Ratio (NP) (%) 23.2321.8316.8821.00
Dividend Payout Ratio (CP) (%) 13.5614.8712.6816.69
Earning Retention Ratio (%) 76.7778.1783.1279.00
Cash Earning Retention Ratio (%) 86.4485.1387.3283.31
Interest Coverage Ratio (X) 15.2216.1915.2635.02
Interest Coverage Ratio (Post Tax) (X) 7.859.359.4522.91
Enterprise Value (Cr.) 1705.421979.481718.711979.92
EV / Net Operating Revenue (X) 0.820.920.770.90
EV / EBITDA (X) 7.597.596.846.82
MarketCap / Net Operating Revenue (X) 0.860.990.740.95
Retention Ratios (%) 76.7678.1683.1178.99
Price / BV (X) 1.061.321.101.49
Price / Net Operating Revenue (X) 0.860.990.740.95
EarningsYield 0.050.060.080.08

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

IOL Chemicals and Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 29/09/1986 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L24116PB1986PLC007030 and registration number is 007030. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 2079.21 Cr. and Equity Capital is Rs. 58.71 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsVillage & Post Office Handiaya, Barnala Punjab 148107Contact not found
Management
NamePosition Held
Mr. Rajender Mohan MallaChairman & Ind.Director
Mr. Varinder GuptaManaging Director
Mr. Vikas GuptaJoint Managing Director
Mr. Abhiraj GuptaExecutive Director
Mr. Kushal Kumar RanaDirector - Works
Mr. Harpal SinghIndependent Director
Mr. Sharad TyagiIndependent Director
Mr. Rajni JhaIndependent Director

FAQ

What is the intrinsic value of IOL Chemicals & Pharmaceuticals Ltd and is it undervalued?

As of 17 April 2026, IOL Chemicals & Pharmaceuticals Ltd's intrinsic value is ₹56.13, which is 27.48% lower than the current market price of ₹77.40, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (6.13 %), book value (₹59.7), dividend yield (1.29 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of IOL Chemicals & Pharmaceuticals Ltd?

IOL Chemicals & Pharmaceuticals Ltd is trading at ₹77.40 as of 17 April 2026, with a FY2026-2027 high of ₹127 and low of ₹57.5. The stock is currently in the middle of its 52-week range. Market cap stands at ₹2,273 Cr..

How does IOL Chemicals & Pharmaceuticals Ltd's P/E ratio compare to its industry?

IOL Chemicals & Pharmaceuticals Ltd has a P/E ratio of 18.2, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is IOL Chemicals & Pharmaceuticals Ltd financially healthy?

Key indicators for IOL Chemicals & Pharmaceuticals Ltd: ROCE of 8.86 % is on the lower side compared to the industry average of 16.35%; ROE of 6.13 % is below ideal levels (industry average: 15.16%). Dividend yield is 1.29 %.

Is IOL Chemicals & Pharmaceuticals Ltd profitable and how is the profit trend?

IOL Chemicals & Pharmaceuticals Ltd reported a net profit of ₹101 Cr in Mar 2025 on revenue of ₹2,079 Cr. Compared to ₹166 Cr in Mar 2022, the net profit shows a declining trend.

Does IOL Chemicals & Pharmaceuticals Ltd pay dividends?

IOL Chemicals & Pharmaceuticals Ltd has a dividend yield of 1.29 % at the current price of ₹77.40. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in IOL Chemicals & Pharmaceuticals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports